MERCK & CO. INC. (MRK)       108.84  +0.39 (+0.36%)

108.84  +0.39 (+0.36%)

US58933Y1055 - Common Stock - Premarket: 108.5 -0.34 (-0.31%)

MERCK & CO. INC.108.84

NYSE:MRK (11/29/2022, 7:04:00 PM)+0.39 (+0.36%)

Premarket: 108.5 -0.34 (-0.31%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Pharmaceuticals
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 10-27 2022-10-27/bmo Earnings (Next) 02-02 2023-02-02
Ins Owners 0.06% Inst Owners 74.22%
Market Cap 275.95B Shares 2.54B
PE 14.21 Fwd PE 14.41
Dividend Yield 2.65% Analysts 77.33
IPO 01-01 1941-01-01

Stock Screener Links

Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

MRK Daily chart

Company Profile

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Kenilworth, New Jersey and currently employs 68,000 full-time employees. The firm offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The company operates through two segments: Pharmaceutical and Animal Health. The firm's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The firm sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Company Info

MERCK & CO. INC.

2000 Galloping Hill Road

Kenilworth NEW JERSEY 07033

P: 19087404000.0

CEO: Kenneth C. Frazier

Employees: 68000

Website: https://www.merck.com/

MRK News

News Image21 hours ago - Seeking AlphaMerck raises dividend by 6% to $0.73

Merck (NYSE:MRK) declares $0.73/share quarterly dividend, 5.8% increase from prior dividend of $0.69.Forward yield 2.7%Payable Jan. 9; for shareholders of record Dec. 15; ex-div Dec.

News Image21 hours ago - Merck & Co., Inc.Merck Announces First-Quarter 2023 DividendNews Imagea day ago - InvestorPlace3 Dow Stocks to Take Seriously in 2023

The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.

News Imagea day ago - The Motley Fool3 Reasons Pfizer Stock Will Crush the Broader Market in 2023

Pfizer's revenue growth is far from over.

News Image2 days ago - Market News VideoNotable Monday Option Activity: MRK, V, FDXNews Image2 days ago - The Motley Fool2 Biotech Stocks You Can Buy and Hold for the Next Decade

These two companies are facing short-term issues that are likely to give way to long-term success.

MRK Twits

Here you can normally see the latest stock twits on MRK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example